Astrazeneca presents case for defense, as Sweden voices concerns on Pfizer bid
Pascal Soriot, CEO of Astrazeneca plc, and his senior management team came out fighting against Pfizer Inc.'s takeover bid Tuesday, setting out an ambitious long-term growth plan for the company based on current growth drivers and a rapidly maturing pipeline which, they claim, will lead to $45 billion in revenue by 2023.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter